In clinical trials, 1 or more local side effects were reported by 3% of patients using penciclovir topical (the active ingredient contained in Denavir) and 4% of patients using placebo.
Common (1% to 10%): Application site reaction (including skin burning sensation, skin pain, hypoesthesia)Frequency not reported: Hypesthesia/local anesthesia, erythematous rash, taste perversion
Frequency not reported: Mild erythemaPostmarketing reports: Allergic dermatitis (including rash, pruritus, blisters, edema), local edema, pain, paresthesia, pruritus, skin discoloration, urticaria, aggravated condition, decreased therapeutic response
Postmarketing reports: Headache, parosmia
Postmarketing reports: Hypersensitivity
Postmarketing reports: Oral/pharyngeal edema
Mild pain, burning, or stinging
Headache
Change in sense of taste
decreased sensitivity of skin, particularly to touch
redness of the skin
skin rash